Log In
Print this Print this

Busulipo (MZH-2)

  Manage Alerts
Collapse Summary General Information
Company Pharmalink AB
DescriptionLiposome formulation of busulfan, a generic chemotherapeutic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationStem cell transplant
Indication DetailsCondition for hematopoietic stem cell transplantation (HSCT)
Regulatory Designation U.S. - Orphan Drug (Condition for hematopoietic stem cell transplantation (HSCT))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today